Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

GenomOncology Names Joshua F. Coleman, M.D. as New VP of Medical Affairs

GenomOncology
Posted on: 30 Nov 16

PR Newswire

CLEVELAND, Nov. 30, 2016

CLEVELAND, Nov. 30, 2016 /PRNewswire/ -- GenomOncology today announced the appointment of Joshua F. Coleman, M.D., as Vice President of Medical Affairs. 

Dr. Coleman will oversee clinical content development and curation of scientific evidence, enhancing the company's proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with a seamless workflow for the interpretation of genetic sequencing data and clinical decision support, from quality control through reporting.

Prior to joining GenomOncology, Dr. Coleman held an appointment of assistant professor at The Ohio State University College of Medicine and practiced molecular genetic pathology in the James Cancer Hospital Molecular Laboratory.  Dr. Coleman completed medical school at Case Western Reserve University, followed by residency in Anatomic and Clinical Pathology at the Cleveland Clinic. He is fellowship-trained and board-certified in Hematopathology and Molecular Genetic Pathology.

"Adding a pathologist to our team has been a long-time goal, and we're confident that with his clinical expertise, Josh will add tremendous value to the direction of our Precision Medicine Portfolio," notes CEO and Founder Manuel Glynias.

Dr. Coleman also brings his strong desire for innovation, drawing upon insights from machine learning and information theory. "Increasingly, the practice of pathology is becoming the practice of data science," states Dr. Coleman. "My driving interest is to extract meaning and present it in the most clear and efficient manner to pathologists, oncologists, and patients. There is a delicate art to communicating just the right information at the right time, but I believe that this is something we can perfect with advanced informatics tools."

About GenomOncology:
GenomOncology is a healthcare technology company enabling precision medicine by transforming genomic data into actionable information.

CONTACT:

Baiju Parikh, VP Sales and Marketing
baiju@genomoncology.com
1375 East 9th Street, Suite 1120
Cleveland, OH 44114
+1-440-617-6087

Logo - http://photos.prnewswire.com/prnh/20140204/CL58248LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/genomoncology-names-joshua-f-coleman-md-as-new-vp-of-medical-affairs-300369217.html

SOURCE GenomOncology

PR Newswire
www.prnewswire.com

Last updated on: 30/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.